PUBLISHER: The Business Research Company | PRODUCT CODE: 1939241
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939241
Apheresis equipment refers to specialized medical devices designed to isolate and extract specific components from blood while returning the remaining components to the donor or patient. These devices are used to separate and remove particular harmful or therapeutic blood elements, such as plasma, white blood cells, platelets, or stem cells, from a donor or patient.
The key types of apheresis equipment include plasmapheresis equipment, photopheresis equipment, low-density lipoprotein (LDL) apheresis equipment, and others. Plasmapheresis equipment is a medical device that isolates and removes plasma from the blood to treat autoimmune and plasma-related disorders, thereby supporting patient recovery. The technologies employed in this equipment include centrifugation and membrane filtration. These devices are applied in areas such as renal diseases, hematology, neurology, and more, with key end-users including hospitals, ambulatory surgical centers (ASCs), blood donation centers, and other healthcare facilities.
Tariffs are impacting the apheresis equipment market by increasing the cost of imported medical devices, precision components, and filtration systems, thereby affecting pricing and procurement strategies for hospitals and blood donation centers. Segments such as photopheresis equipment and membrane filtration systems are most affected, particularly in regions like Asia-Pacific and North America where imports are significant. While tariffs create short-term cost pressures and supply chain disruptions, they also incentivize local manufacturing, encourage innovation in device design, and strengthen domestic production capabilities over time.
The apheresis equipment market research report is one of a series of new reports from The Business Research Company that provides apheresis equipment market statistics, including apheresis equipment industry global market size, regional shares, competitors with a apheresis equipment market share, detailed apheresis equipment market segments, market trends and opportunities, and any further data you may need to thrive in the apheresis equipment industry. This apheresis equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The apheresis equipment market size has grown rapidly in recent years. It will grow from $4.33 billion in 2025 to $4.88 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to limited access to automated apheresis equipment, growing prevalence of renal and hematologic disorders, increasing blood donation initiatives, adoption of centrifugation-based systems, regulatory guidelines for patient safety.
The apheresis equipment market size is expected to see rapid growth in the next few years. It will grow to $7.77 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to technological advancements in photopheresis and ldl apheresis, rising investment in automated and membrane-based systems, expansion of hospital and asc infrastructure, increasing demand for personalized and precision therapies, growing awareness and adoption of therapeutic apheresis globally. Major trends in the forecast period include rising demand for automated apheresis systems, increasing use of apheresis in hematology and renal therapies, growing adoption of membrane filtration technologies, expansion of blood donation and therapeutic centers, emphasis on patient safety and quality control standards.
The increasing incidence of blood disorders is anticipated to drive the growth of the apheresis equipment market in the coming years. Hemophilia is an inherited blood condition marked by a lack of clotting factors, resulting in extended bleeding episodes and the need for specialized therapies such as plasma and clotting factor replacement. The growing hemophilia patient population is attributed to better diagnostic capabilities, improved reporting practices, and overall population growth. Apheresis equipment plays a crucial role in the effective management of hemophilia by allowing accurate separation and collection of specific blood components for therapeutic purposes, thereby enhancing treatment effectiveness and patient outcomes. For example, in October 2024, according to the World Federation of Hemophilia, a Canada-based organization, there were 390,630 identified hemophilia patients across 119 countries in 2023. Hence, the rising prevalence of blood disorders is contributing to the expansion of the apheresis equipment market.
Companies in the apheresis equipment market are focusing on developing innovative products, such as advanced venous access techniques, to enhance patient comfort, reduce procedure duration, and improve treatment efficiency. Venous access techniques involve technologies designed to make the insertion of needles or catheters into veins safer, easier, and more efficient. For instance, in April 2023, Fresenius Kabi AG, a Germany-based medical technology company, introduced a single-needle venous access option for its Amicus extracorporeal photopheresis (ECP) system. This solution allows clinicians to seamlessly switch between single-needle and double-needle access during procedures, includes advanced software upgrades, and utilizes a single-use disposable kit for easy setup, further streamlining clinical workflows. It enhances patient comfort, minimizes the risk of complications, and improves the overall efficiency of apheresis treatments.
In November 2024, Macopharma International Group S.A.S., a France-based medical device company, acquired Lmb Technologie GmbH for an undisclosed amount. Through this acquisition, Macopharma seeks to expand its blood processing solutions, strengthen its global presence, and drive growth by integrating Lmb Technologie's expertise. Lmb Technologie GmbH, based in Germany, specializes in providing apheresis equipment.
Major companies operating in the apheresis equipment market are Asahi Kasei Medical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Terumo Blood and Cell Technologies Inc., Kaneka Corporation, Sumitomo Bakelite Co. Ltd., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma S.A., B. Braun Melsungen AG, Cerus Corporation, Infomed S.A., Medica S.p.A., Baihe Medical Technology Co. Ltd., Brightwake Limited, Kawasumi Laboratories Inc., Haier Biomedical Co. Ltd., Nigale Biomedical Inc., Apheresis Technologies LLC
North America was the largest region in the apheresis equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the apheresis equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the apheresis equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The apheresis equipment market consists of revenues earned by entities by providing services such as blood component separation, plasma exchange, photopheresis treatment, therapeutic plasma exchange, and related maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The apheresis equipment market also includes sales of centrifugal apheresis machines, membrane filtration devices, blood cell separators, plasma separators, and platelet separators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Apheresis Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses apheresis equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for apheresis equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The apheresis equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.